Baillie Gifford China Growth Trust (BGCG) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
26 Feb, 2026Executive summary
Achieved a NAV total return of 35.4% for the year to 31 January 2025, outperforming the MSCI China All Shares Index benchmark by 3%.
Share price total return was 29.4%, slightly underperforming the benchmark due to a widening discount.
Government stimulus and policy shifts in China drove a substantial rally in equities, benefiting growth strategies.
Board actions included a 4.5% share buyback, introduction of a performance-related Conditional Tender Offer for 2028, and renewal of the loan facility.
Portfolio focused on high-conviction growth companies, with significant exposure to technology, consumer, and industrial sectors.
Financial highlights
NAV per share increased from 193.06p to 259.07p, a 34.2% rise year-over-year.
Shareholders' funds rose to £153.1m from £119.4m, up 28.3%.
Revenue earnings per share grew 4.5% to 2.53p.
Final dividend proposed at 2.20p, a 10% increase.
Ongoing charges ratio increased slightly to 1.12%.
Discount to NAV widened to 10.4% from 6.2%.
Portfolio turnover was 19.1%.
Outlook and guidance
Board remains positive on long-term prospects for China, citing structural growth drivers in technology, manufacturing, and consumption.
Volatility expected to persist due to geopolitical and economic uncertainties.
Conditional Tender Offer in 2028 provides downside protection if NAV total return underperforms the benchmark.
Valuations remain attractive, with Chinese equities trading at a 45% discount to global markets.